For a complete BO, BP probably thinks less than $5 a share would be more than generous. For all HIV indications worldwide they'd probably offer us $25 million upfront and 10%. BP won't began to properly valuate us until prescriptions for combo start rising and results from Phase 2 mTNBC come in. Even then it will be a low ball offer for what we have.